Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

044. COVID-19: Complications, Coinfections and Clinical Outcomes: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes

(398) Increased Risk of Severe COVID-19 Outcomes Across all Groups of Individuals with Hematological Malignancies, Solid Tumors, and Solid Organ Transplants Compared with the General Population: Initial Results from INFORM, a Retrospective Health Database Observational Study in England

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C

    Presenting Author(s)

  • RM

    Richard McNulty, MD

    Medical Affairs, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK
    Cambridge, England, United Kingdom

    • Co-Author(s)

  • SD

    Sabada Dube, PhD

    Director of Epidemiology
    Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca
    Cambridge, England, United Kingdom

    • Co-Author(s)

  • YL

    Yi Lu, PhD

    Real-World Evidence, Data Analytics, Evidera, London, UK
    London, England, United Kingdom

  • SG

    Sophie Graham, MSc

    Real-World Evidence, Data Analytics, Evidera, London, UK
    London, England, United Kingdom

  • SA

    Sofie Arnetorp, MS

    Health Economics and Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
    Gothenburg, Vastra Gotaland, Sweden

  • NJ

    Nahila Justo, PhD, MBA

    Real-World Evidence, Data Analytics, Evidera, Stockholm, Sweden and Department of Neurobiology, Care Science and Society, Karolinska Institute, Stockholm, Sweden
    Stockholm, Sodermanlands Lan, Sweden

  • RY

    Renata Yokota, PhD

    P95, Leuven, Belgium
    Dilbeek, Luxembourg, Belgium

  • KE

    Kathryn Evans, MPH

    Real-World Evidence, Data Analytics, Evidera, Waltham, MA, USA
    Waltham, Massachusetts, United States

  • SV

    Sudhir Venkatesan, MPH, PhD

    Medical and Payer Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Cambridge, UK
    Cambridge, England, United Kingdom

  • MY

    Mark Yates, PhD

    Real-World Evidence, Data Analytics, Evidera, London, UK
    London, England, United Kingdom

  • ST

    Sylvia Taylor, PhD, MPH, MBA

    Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK
    Cambridge, England, United Kingdom

  • JQ

    Jennifer Quint, PhD

    National Heart and Lung Institute, Imperial College London, London, UK
    Cambridge, England, United Kingdom

  • RE

    Rachael A. Evans, PhD FRCP

    Associate Professor and Honorary Respiratory Consultant Physician
    University of Leicester
    Leicester, England, United Kingdom